Market research
MAB.WAR Mabion S.A.
WAR PLN Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 130M
- P/E ratio
- Not available
- Analyst target
- 10
- Dividend yield
- Not available
- Beta
- 0.42
Community
Investor discussion
1 comment
Sign in to join the MAB.WAR discussion.
5 years, 6 months ago
Mabion S.A. is currently in a long term uptrend where the price is trading 53.2% above its 200 day moving average.
Its net income has increased by 45.5% to $-9M since the same quarter in the previous year.
Finally, its free cash flow grew by 10.2% to $-29M since the same quarter in the previous year.
Based on the above factors, Mabion S.A. gets an overall score of 3/5.